Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06577792

Lobectomy-First vs. Lymphadenectomy-First for Operable NSCLC (LOFTY)

Lobectomy-First Versus Lymphadenectomy-First Surgical Approach on Long-Term Survival in Operable Non-Small Cell Lung Cancer Patients: A Prospective, Multi-Center, Randomized Study

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
620 (estimated)
Sponsor
Sun Yat-sen University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

During the surgery for non-small cell lung cancer (NSCLC), lymphadenectomy or lobectomy are performed first, different surgeons have different choices. Oncology textbooks require dissecting distant lymph nodes (LNs) first and then dissecting nearby LNs. According to this requirement, thoracic surgeons should first perform lymphadenectomy and then lobectomy. Unfortunately, there is no high-level evidence to prove which surgical sequence is more beneficial to the long-term survival of NSCLC patients. In this multi-center randomized controlled trial (RCT), patients with stage I-II NSCLC were enrolled as the research object to determine which surgical sequence (lymphadenectomy-first vs. lobectomy-first) is better for the short-term and long-term outcomes in NSCLC patients.

Conditions

Interventions

TypeNameDescription
PROCEDURELobectomy-FirstDuring the surgical treatment for patients with NSCLC, thoracic surgeons should perform lobectomy first, and then perform lymphadenectomy next.
PROCEDURELymphadenectomy-FirstDuring the surgical treatment for patients with NSCLC, thoracic surgeons should perform lymphadenectomy first, and then perform lobectomy next.

Timeline

Start date
2023-08-16
Primary completion
2025-12-31
Completion
2030-12-31
First posted
2024-08-29
Last updated
2025-05-16

Locations

26 sites across 1 country: China

Source: ClinicalTrials.gov record NCT06577792. Inclusion in this directory is not an endorsement.